NextNav (NASDAQ:NN – Free Report) had its price target increased by B. Riley from $12.00 to $20.00 in a report released on Thursday morning, Marketbeat reports. They currently have a buy rating on the stock.
NextNav Trading Up 0.5 %
Shares of NASDAQ:NN opened at $14.22 on Thursday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.93 and a current ratio of 5.01. The stock has a market capitalization of $1.83 billion, a price-to-earnings ratio of -18.96 and a beta of 0.94. NextNav has a 1-year low of $3.55 and a 1-year high of $17.02. The company has a 50 day moving average price of $9.55 and a 200 day moving average price of $8.43.
Insider Buying and Selling
In other NextNav news, Director Neil S. Subin bought 100,000 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was acquired at an average price of $6.92 per share, with a total value of $692,000.00. Following the completion of the transaction, the director now directly owns 2,365,213 shares in the company, valued at approximately $16,367,273.96. This represents a 4.41 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 15.70% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On NextNav
NextNav Company Profile
NextNav Inc provides next generation positioning, navigation, and timing (PNT) solutions in the United States. It offers Pinnacle, a dedicated vertical positioning network to cover entire metropolitan areas including devices equipped with a barometric pressure sensor with the highest quality wide-area altitude service.
See Also
- Five stocks we like better than NextNav
- Canada Bond Market Holiday: How to Invest and Trade
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Most active stocks: Dollar volume vs share volume
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Top Biotech Stocks: Exploring Innovation Opportunities
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for NextNav Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextNav and related companies with MarketBeat.com's FREE daily email newsletter.